After months of speculation and years of debate, the U.S. Food and Drug Administration (FDA) today issued a final regulation classifying dental amalgam and its component parts as class II medical devices -- even as the agency insists that amalgam poses no health risks.
FDA follows through on plan to reclassify dental amalgam
Jul 27, 2009
Latest in Regulatory Updates
Sign up for the 2026 State of Compliance Address
January 7, 2026
FDA OKs trial for RevBio's dental bone glue
December 27, 2025
FDA OKs Mesosil's dental antimicrobial system
December 23, 2025



















